Global Coalition for Adaptive Research - Driving Progress for Patients – Faster. Together.
Driving Progress for Patients – Faster. Together.
DONATE
Meet GCAR
About Us
Executive Team
Board of Directors
Trials Leadership
Global Sites
Contact Us
Discover Our Research
Master Protocols & Adaptive Platform Trials
GBM AGILE
GBM AGILE | Overview
Leadership Council
Trial Sites
Partners
Patient FAQs
REMAP-CAP / COVID
REMAP-CAP / COVID | Overview
US Steering Committee
Trial Sites
Partners
Patient FAQs
IN DEVELOPMENT
OVARIAN CANCERX
OVARIAN CANCERX | Overview
Leadership
Partners
Biliary Tract Cancer Master Protocol | Overview
Neurofibromatosis Platform Trial | Overview
Pancreatic Cancer Master Protocol | Overview
Get News + Publications
Scientific Presentations + Publications
Educational Resources
Video Resources
Educational Materials
News + Announcements
Make Progress
Support a Trial
Partner With Us
Contact Us
DONATE
Toggle menu
Oncolytics Biotech® Announces Preliminary Collaboration with GCAR for Inclusion of Pelareorep in Anticipated Pancreatic Cancer Trial
⃪ Back to News + Announcements
Oncolytics Biotech® Announces Preliminary Collaboration with GCAR for Inclusion of Pelareorep in Anticipated Pancreatic Cancer Trial
May 15, 2024 |
PRNewswire